275 related articles for article (PubMed ID: 21057081)
1. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients.
de Kruijf EM; Sajet A; van Nes JG; Natanov R; Putter H; Smit VT; Liefers GJ; van den Elsen PJ; van de Velde CJ; Kuppen PJ
J Immunol; 2010 Dec; 185(12):7452-9. PubMed ID: 21057081
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
de Kruijf EM; van Nes JG; Sajet A; Tummers QR; Putter H; Osanto S; Speetjens FM; Smit VT; Liefers GJ; van de Velde CJ; Kuppen PJ
Clin Cancer Res; 2010 Feb; 16(4):1272-80. PubMed ID: 20145162
[TBL] [Abstract][Full Text] [Related]
3. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
4. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of human leukocyte antigen-G expression and its clinical significance in ductal breast cancer.
Chen HX; Lin A; Shen CJ; Zhen R; Chen BG; Zhang X; Cao FL; Zhang JG; Yan WH
Hum Immunol; 2010 Sep; 71(9):892-8. PubMed ID: 20547193
[TBL] [Abstract][Full Text] [Related]
6. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
[TBL] [Abstract][Full Text] [Related]
7. Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients.
de Kruijf EM; Engels CC; van de Water W; Bastiaannet E; Smit VT; van de Velde CJ; Liefers GJ; Kuppen PJ
Breast Cancer Res Treat; 2013 Nov; 142(2):355-64. PubMed ID: 24197659
[TBL] [Abstract][Full Text] [Related]
8. HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
He X; Dong DD; Yie SM; Yang H; Cao M; Ye SR; Li K; Liu J; Chen J
Ann Surg Oncol; 2010 May; 17(5):1459-69. PubMed ID: 20052552
[TBL] [Abstract][Full Text] [Related]
9. The antigen processing machinery of class I human leukocyte antigens: linked patterns of gene expression in neoplastic cells.
Giorda E; Sibilio L; Martayan A; Moretti S; Venturo I; Mottolese M; Ferrara GB; Cappellacci S; Eibenschutz L; Catricalà C; Grammatico P; Giacomini P
Cancer Res; 2003 Jul; 63(14):4119-27. PubMed ID: 12874016
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
Bijen CB; Bantema-Joppe EJ; de Jong RA; Leffers N; Mourits MJ; Eggink HF; van der Zee AG; Hollema H; de Bock GH; Nijman HW
Int J Cancer; 2010 Mar; 126(6):1417-27. PubMed ID: 19728333
[TBL] [Abstract][Full Text] [Related]
11. HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.
Sayed D; Badr G; Maximous D; Mikhail NN; Abu-Tarboush F; Alhazza IM
Tissue Antigens; 2010 Jan; 75(1):40-7. PubMed ID: 20196818
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
Ibrahim EC; Guerra N; Lacombe MJ; Angevin E; Chouaib S; Carosella ED; Caignard A; Paul P
Cancer Res; 2001 Sep; 61(18):6838-45. PubMed ID: 11559559
[TBL] [Abstract][Full Text] [Related]
14. Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients.
de Kruijf EM; van Nes JG; van de Velde CJ; Putter H; Smit VT; Liefers GJ; Kuppen PJ; Tollenaar RA; Mesker WE
Breast Cancer Res Treat; 2011 Feb; 125(3):687-96. PubMed ID: 20361254
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
[TBL] [Abstract][Full Text] [Related]
16. HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
Rouas-Freiss N; Moreau P; Ferrone S; Carosella ED
Cancer Res; 2005 Nov; 65(22):10139-44. PubMed ID: 16287995
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
Paul P; Cabestré FA; Le Gal FA; Khalil-Daher I; Le Danff C; Schmid M; Mercier S; Avril MF; Dausset J; Guillet JG; Carosella ED
Cancer Res; 1999 Apr; 59(8):1954-60. PubMed ID: 10213506
[TBL] [Abstract][Full Text] [Related]
18. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?
Kren L; Slaby O; Muckova K; Lzicarova E; Sova M; Vybihal V; Svoboda T; Fadrus P; Lakomy R; Vanhara P; Krenova Z; Sterba J; Smrcka M; Michalek J
Neuropathology; 2011 Apr; 31(2):129-34. PubMed ID: 20667016
[TBL] [Abstract][Full Text] [Related]
19. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
20. HLA-G expression in gastric cancer.
Ishigami S; Natsugoe S; Miyazono F; Nakajo A; Tokuda K; Matsumoto M; Okumura H; Douchi T; Hokita S; Aikou T
Anticancer Res; 2006; 26(3B):2467-72. PubMed ID: 16821634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
